JP2005525817A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005525817A5 JP2005525817A5 JP2004506471A JP2004506471A JP2005525817A5 JP 2005525817 A5 JP2005525817 A5 JP 2005525817A5 JP 2004506471 A JP2004506471 A JP 2004506471A JP 2004506471 A JP2004506471 A JP 2004506471A JP 2005525817 A5 JP2005525817 A5 JP 2005525817A5
- Authority
- JP
- Japan
- Prior art keywords
- embryo
- cell
- ungulate
- oocyte
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 claims 102
- 210000001161 mammalian embryo Anatomy 0.000 claims 101
- 238000000034 method Methods 0.000 claims 75
- 210000000287 oocyte Anatomy 0.000 claims 48
- 108020004707 nucleic acids Proteins 0.000 claims 36
- 102000039446 nucleic acids Human genes 0.000 claims 36
- 150000007523 nucleic acids Chemical class 0.000 claims 36
- 108010077544 Chromatin Proteins 0.000 claims 32
- 210000003483 chromatin Anatomy 0.000 claims 32
- 210000004940 nucleus Anatomy 0.000 claims 29
- 108090000623 proteins and genes Proteins 0.000 claims 23
- 210000003754 fetus Anatomy 0.000 claims 21
- 230000035772 mutation Effects 0.000 claims 20
- 238000004519 manufacturing process Methods 0.000 claims 18
- 102000004169 proteins and genes Human genes 0.000 claims 18
- 210000000349 chromosome Anatomy 0.000 claims 16
- 230000009261 transgenic effect Effects 0.000 claims 16
- 210000004291 uterus Anatomy 0.000 claims 14
- 238000003780 insertion Methods 0.000 claims 12
- 230000037431 insertion Effects 0.000 claims 12
- 239000012634 fragment Substances 0.000 claims 10
- 230000008707 rearrangement Effects 0.000 claims 10
- 108060003951 Immunoglobulin Proteins 0.000 claims 9
- 108700005091 Immunoglobulin Genes Proteins 0.000 claims 9
- 102000018358 immunoglobulin Human genes 0.000 claims 9
- 230000005030 transcription termination Effects 0.000 claims 9
- 238000000338 in vitro Methods 0.000 claims 8
- 230000001776 parthenogenetic effect Effects 0.000 claims 8
- 210000002257 embryonic structure Anatomy 0.000 claims 7
- 230000001605 fetal effect Effects 0.000 claims 7
- 210000002950 fibroblast Anatomy 0.000 claims 7
- 230000008672 reprogramming Effects 0.000 claims 7
- 239000000427 antigen Substances 0.000 claims 6
- 108091007433 antigens Proteins 0.000 claims 6
- 102000036639 antigens Human genes 0.000 claims 6
- 239000012528 membrane Substances 0.000 claims 6
- 210000003719 b-lymphocyte Anatomy 0.000 claims 5
- 108700028369 Alleles Proteins 0.000 claims 4
- 241000283690 Bos taurus Species 0.000 claims 4
- 241000283707 Capra Species 0.000 claims 4
- 230000004543 DNA replication Effects 0.000 claims 4
- 241001494479 Pecora Species 0.000 claims 4
- 241000282898 Sus scrofa Species 0.000 claims 4
- 230000015572 biosynthetic process Effects 0.000 claims 4
- 230000032823 cell division Effects 0.000 claims 4
- 230000002759 chromosomal effect Effects 0.000 claims 4
- 238000011534 incubation Methods 0.000 claims 4
- 210000004080 milk Anatomy 0.000 claims 4
- 239000008267 milk Substances 0.000 claims 4
- 235000013336 milk Nutrition 0.000 claims 4
- 239000012266 salt solution Substances 0.000 claims 4
- 210000002966 serum Anatomy 0.000 claims 4
- 239000000243 solution Substances 0.000 claims 4
- 241000894007 species Species 0.000 claims 4
- 239000004094 surface-active agent Substances 0.000 claims 4
- 230000003115 biocidal effect Effects 0.000 claims 3
- 210000004602 germ cell Anatomy 0.000 claims 3
- 239000003550 marker Substances 0.000 claims 3
- 210000002826 placenta Anatomy 0.000 claims 3
- 108020004705 Codon Proteins 0.000 claims 2
- 102000001253 Protein Kinase Human genes 0.000 claims 2
- 108700019146 Transgenes Proteins 0.000 claims 2
- 210000000601 blood cell Anatomy 0.000 claims 2
- 210000001612 chondrocyte Anatomy 0.000 claims 2
- 210000002308 embryonic cell Anatomy 0.000 claims 2
- 210000001339 epidermal cell Anatomy 0.000 claims 2
- 210000002919 epithelial cell Anatomy 0.000 claims 2
- 210000003743 erythrocyte Anatomy 0.000 claims 2
- 230000004927 fusion Effects 0.000 claims 2
- 210000002510 keratinocyte Anatomy 0.000 claims 2
- 210000002540 macrophage Anatomy 0.000 claims 2
- 230000013011 mating Effects 0.000 claims 2
- 210000002752 melanocyte Anatomy 0.000 claims 2
- 230000000394 mitotic effect Effects 0.000 claims 2
- 210000001616 monocyte Anatomy 0.000 claims 2
- 210000000107 myocyte Anatomy 0.000 claims 2
- 210000002569 neuron Anatomy 0.000 claims 2
- 230000003169 placental effect Effects 0.000 claims 2
- 108060006633 protein kinase Proteins 0.000 claims 2
- 102000002322 Egg Proteins Human genes 0.000 claims 1
- 108010000912 Egg Proteins Proteins 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 210000003855 cell nucleus Anatomy 0.000 claims 1
- 210000001671 embryonic stem cell Anatomy 0.000 claims 1
- 210000004996 female reproductive system Anatomy 0.000 claims 1
- 210000002980 germ line cell Anatomy 0.000 claims 1
- 210000004408 hybridoma Anatomy 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- 201000000050 myeloid neoplasm Diseases 0.000 claims 1
- 210000004681 ovum Anatomy 0.000 claims 1
- 210000001082 somatic cell Anatomy 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- 238000003757 reverse transcription PCR Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 2
- 101000639792 Homo sapiens U2 small nuclear ribonucleoprotein A' Proteins 0.000 description 1
- 102100034465 U2 small nuclear ribonucleoprotein A' Human genes 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38153102P | 2002-05-17 | 2002-05-17 | |
| US42505602P | 2002-11-08 | 2002-11-08 | |
| PCT/US2003/015937 WO2003097812A2 (en) | 2002-05-17 | 2003-05-19 | Transgenic ungulates capable of human antibody production |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005525817A JP2005525817A (ja) | 2005-09-02 |
| JP2005525817A5 true JP2005525817A5 (https=) | 2006-11-24 |
Family
ID=29553536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004506471A Pending JP2005525817A (ja) | 2002-05-17 | 2003-05-19 | ヒト抗体産生が可能なトランスジェニック有蹄動物 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1513397B1 (https=) |
| JP (1) | JP2005525817A (https=) |
| KR (1) | KR20050000558A (https=) |
| CN (1) | CN1668187A (https=) |
| AT (1) | ATE464389T1 (https=) |
| CA (1) | CA2484655A1 (https=) |
| DE (1) | DE60332111D1 (https=) |
| IL (1) | IL165088A0 (https=) |
| NZ (1) | NZ536341A (https=) |
| WO (1) | WO2003097812A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0110029D0 (en) | 2001-04-24 | 2001-06-13 | Grosveld Frank | Transgenic animal |
| AU2005237494B2 (en) * | 2004-04-22 | 2010-06-10 | Kyowa Hakko Kirin Co., Ltd | Transgenic animals and uses thereof |
| NZ551832A (en) * | 2004-06-09 | 2010-01-29 | Univ Edinburgh | Neural stem cells |
| CA2958259C (en) * | 2004-10-22 | 2020-06-30 | Revivicor, Inc. | Ungulates with genetically modified immune systems |
| TW200817512A (en) | 2006-07-07 | 2008-04-16 | Kirin Pharma Kk | Human artificial chromosome (hac) vector, and human cell pharmaceutical comprising human artificial chromosome (hac) vector |
| DK2348827T3 (en) | 2008-10-27 | 2015-07-20 | Revivicor Inc | IMMUNICIPLY COMPROMATED PETS |
| EP3187581A1 (en) | 2008-12-23 | 2017-07-05 | BOCO Silicon Valley, Inc. | Target populations of oligodendrocyte precursor cells and methods of making and using same |
| PT3345593T (pt) | 2009-11-13 | 2023-11-27 | Sanofi Aventis Deutschland | Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina |
| EP2502993B1 (en) | 2009-11-17 | 2017-07-26 | Sanford Applied Biosciences L.L.C. | Human artificial chromosome vector |
| AU2013296182B2 (en) * | 2012-08-03 | 2018-03-08 | Sab, Llc | Complex chromosome engineering for production of human antibodies in transgenic animals |
| CN105358577A (zh) * | 2013-02-13 | 2016-02-24 | 法国化学与生物科技实验室 | 具有经修饰的糖基化的西妥昔单抗及其用途 |
| CA2909139C (en) * | 2013-04-18 | 2021-07-06 | Institut National De La Sante Et De La Recherche Medicale | Composition with reduced immunogenicity |
| EP3207055A1 (en) * | 2014-10-15 | 2017-08-23 | Xenothera | Composition with reduced immunogenicity |
| CN115362172A (zh) * | 2020-02-12 | 2022-11-18 | Sab有限责任公司 | 抗胸腺细胞球蛋白 |
| EP4665391A1 (en) * | 2023-02-17 | 2025-12-24 | Sab, Llc | Ungulate-derived polyclonal immunoglobulin specific for influenza virus and uses thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996033735A1 (en) | 1995-04-27 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US5652373A (en) * | 1990-01-15 | 1997-07-29 | Yeda Research And Development Co. Ltd. | Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems |
| US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5545806A (en) * | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| ATE158021T1 (de) * | 1990-08-29 | 1997-09-15 | Genpharm Int | Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper |
| US6300129B1 (en) | 1990-08-29 | 2001-10-09 | Genpharm International | Transgenic non-human animals for producing heterologous antibodies |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| US5789655A (en) * | 1994-05-13 | 1998-08-04 | The Regents Of The University Of California | Transgenic animals expressing artificial epitope-tagged proteins |
| KR100308764B1 (ko) * | 1995-08-29 | 2001-12-17 | 마나배게이사꾸 | 키메라동물및그의제작법 |
| CA2722378C (en) | 1996-12-03 | 2015-02-03 | Amgen Fremont Inc. | Human antibodies that bind tnf.alpha. |
| WO2001035735A1 (en) * | 1999-11-19 | 2001-05-25 | Hematech, Llc | Production of ungulates, preferably bovines that produce human immunoglobulins |
| AU2001297523B2 (en) * | 2000-11-17 | 2007-01-18 | Sab, Llc | Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| US20020108132A1 (en) * | 2001-02-02 | 2002-08-08 | Avigenics Inc. | Production of a monoclonal antibody by a transgenic chicken |
-
2003
- 2003-05-19 CN CNA038167425A patent/CN1668187A/zh active Pending
- 2003-05-19 IL IL16508803A patent/IL165088A0/xx unknown
- 2003-05-19 AT AT03738939T patent/ATE464389T1/de not_active IP Right Cessation
- 2003-05-19 KR KR10-2004-7018599A patent/KR20050000558A/ko not_active Ceased
- 2003-05-19 CA CA002484655A patent/CA2484655A1/en not_active Abandoned
- 2003-05-19 EP EP03738939A patent/EP1513397B1/en not_active Expired - Lifetime
- 2003-05-19 WO PCT/US2003/015937 patent/WO2003097812A2/en not_active Ceased
- 2003-05-19 DE DE60332111T patent/DE60332111D1/de not_active Expired - Lifetime
- 2003-05-19 JP JP2004506471A patent/JP2005525817A/ja active Pending
- 2003-05-19 NZ NZ536341A patent/NZ536341A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230133028A1 (en) | Transgenic mice | |
| CN103429746B (zh) | Adam6小鼠 | |
| CN1486365B (zh) | 异种(人类)免疫球蛋白在克隆转基因有蹄类动物中的表达 | |
| ES3057292T3 (en) | Humanized light chain mice | |
| JP2007533328A (ja) | トランスジェニック動物及びその用途 | |
| JP2005525817A5 (https=) | ||
| US20140359795A1 (en) | Genetic techniques for making animals with sortable sperm | |
| JP2005504507A5 (https=) | ||
| RU2005117629A (ru) | Трансгенные копытные животные, имеющие пониженную активность прионного белка, и их применения | |
| JP2002528117A (ja) | トランスジェニックおよびクローン哺乳動物 | |
| KR20050000558A (ko) | 인간 항체를 제조할 수 있는 트랜스제닉 유제동물 | |
| KR20180128386A (ko) | 유전적 상보성에 의한 인간화 신장의 조작 | |
| JP7578306B2 (ja) | 動物の製造方法 | |
| JP4845073B2 (ja) | 再構築受精卵の作製方法及びそれを用いたトランスジェニック胚の作製方法 | |
| HK40073129A (en) | Adam6 mice | |
| WO2021200768A1 (ja) | ヒト染色体の分散方法、単離方法、およびその動物胚への移植方法 | |
| WO2006048954A1 (ja) | 異種移植用豚細胞、その選抜方法及び異種移植用豚 | |
| Spell et al. | 15 Somatic Cell Cloning in the Beef | |
| WO2001001766A1 (en) | Animal defective in uti gene function | |
| BR122023011479B1 (pt) | Método para produzir uma proteína de ligação ao antígeno humano que se liga a um antígeno de interesse, método para produzir uma célula es animal não humana geneticamente modificada, método para modificar um locus de imunoglobulina de cadeia pesada de uma célula es de camundongo e método para produzir uma sequência de nucleotídeos que codifica uma cadeia leve de imunoglobulina totalmente humana |